HY-10254-5mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-50mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-1mL
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-129123-10mg
|
MedChemexpress LLC
|
ML318 [CAS 1610516-67-0]
|
|
COVID-19-immunoregulation
|
|
HY-129123-100mg
|
MedChemexpress LLC
|
ML318 [CAS 1610516-67-0]
|
|
COVID-19-immunoregulation
|
|
HY-129123-25mg
|
MedChemexpress LLC
|
ML318 [CAS 1610516-67-0]
|
|
COVID-19-immunoregulation
|
|
HY-129123-5mg
|
MedChemexpress LLC
|
ML318 [CAS 1610516-67-0]
|
|
COVID-19-immunoregulation
|
|
HY-129123-50mg
|
MedChemexpress LLC
|
ML318 [CAS 1610516-67-0]
|
|
COVID-19-immunoregulation
|
|
HY-129123-1mL
|
MedChemexpress LLC
|
ML318 [CAS 1610516-67-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-123561-10mg
|
MedChemexpress LLC
|
MMV008138 [CAS 1679333-73-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-123561-100mg
|
MedChemexpress LLC
|
MMV008138 [CAS 1679333-73-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-123561-5mg
|
MedChemexpress LLC
|
MMV008138 [CAS 1679333-73-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-123561-50mg
|
MedChemexpress LLC
|
MMV008138 [CAS 1679333-73-3]
|
|
Neuroscience-Neuromodulation
|
|
HY-123561-1mL
|
MedChemexpress LLC
|
MMV008138 [CAS 1679333-73-3] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|